Who to call at VIVA In Vitro Diagnostics, and when
Fundz watches for the moments VIVA In Vitro Diagnostics starts buying, and tells you who to reach.
- An alert the day VIVA In Vitro Diagnostics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at VIVA In Vitro Diagnostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at VIVA In Vitro Diagnostics. With Fundz connected, it knows.
VIVA In Vitro Diagnostics and ASKA Biotech Form Strategic Partnership to Enhance VIVA-ELISA® Manufacturing.
Contract Type
partnership
SpainBiotechnologyDescription
VIVA In Vitro Diagnostics and ASKA Biotech GmbH have partnered to advance the development of VIVA-ELISA®. The collaboration aims to leverage ASKA's expertise in manufacturing to bring a Research Use Only product to market by Q2 2027.
Other recent agreements in Biotechnology
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- JD Technologies Global and FRIWO North America Form Strategic Partnership to Enhance U.S. Medical Market Access (November 4, 2026)
- Wildcat Defense partners with Taqtile to deploy digital tools in shipyards. (November 4, 2026)
- Physiomics Wins New Contract for Drug Development Modelling Services (November 4, 2026)
- Evommune Enters Exclusive License Agreement with Hinova Pharmaceuticals (November 4, 2026)
- AbbVie secures exclusive licensing rights to Nxera’s EP4 program for inflammatory bowel disease with a $100 million payment. (November 4, 2026)
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
Agreement Insights
What this usually meansVIVA In Vitro Diagnostics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.